(Q53436797)
Statements
A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia. (English)
1 reference
Laura Redden
1 reference
Beatrice Rendenbach-Mueller
1 reference
Walid M Abi-Saab
1 reference
David A Katz
1 reference
Armen Goenjian
1 reference
Weining Z Robieson
1 reference
Yaqin Wang
1 reference
Sandra L Goss
1 reference
Nicholas Greco
1 reference
Mario D Saltarelli
1 reference
1 April 2011
1 reference
31
1 reference
2
1 reference
221-225
1 reference
Identifiers
1 reference